<DOC>
	<DOCNO>NCT01324024</DOCNO>
	<brief_summary>The purpose study determine whether medication call VyvanseÂ® ( lisdexamfetamine ; LDX ) impact cognitive functioning , specifically measure sustain attention , verbal encode recall work memory , menopausal age woman . LDX medication use treat attention deficit hyperactivity disorder ( ADHD ) . The cognitive difficulty menopausal woman report experience typical adult diagnose ADHD . The investigator assess whether LDX effective alleviate cognitive disruption compare placebo .</brief_summary>
	<brief_title>Attention &amp; Memory Impairments Menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Women age 45 60 eligible study : Are within 5 year last menstrual period ; Are able give write informed consent ; Must clear urine toxicology screen upon recruitment ; Are fluent write spoken English ; Must negative urine pregnancy test still menstruate . History seizures ; History cardiac disease include know cardiac defect conduction abnormality ; Abnormal electrocardiogram screening ; Use estrogen therapy within previous 6 month ; Current pregnancy planning become pregnant . Presence contraindication treatment stimulant medication ; would include presence hypertension , coronary disease , atrial fibrillation , arrhythmia .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Aging</keyword>
	<keyword>Memory</keyword>
	<keyword>Women</keyword>
</DOC>